Character Biosciences logo

Character Biosciences

A patient-driven drug discovery platform for diseases of aging

36 employees · est. 2019 · San Francisco, United States

VS
Prevail Therapeutics logo

Prevail Therapeutics

Wholly owned subsidiary of Eli Lilly and Company

17 employees · est. 2017 · New York, United States

Prevail Therapeutics is the older company (2019 vs 2017).

Side-by-Side Comparison

Character Biosciences Prevail Therapeutics
Founded
2019 2017 older
Headquarters
San Francisco, United States New York, United States
Employees
36 17
Industry
Biotechnology, Health Care, Pharmaceutical Biotechnology
Funding Stage
Series A Acquired
Total Funding
$27.00M $1.29B
Funding Rounds
4 5
Services
Not tracked yet Development of gene therapies, Clinical trial management
Target Customers
Not tracked yet Patients with neurodegenerative diseases, Patients with rare genetic disorders, Healthcare providers, Medical researchers
Taxonomy
Precision Medicine, Drug Discovery, Patient-driven, Genomics, Clinical Research, Therapeutics, Aging Diseases, Molecular Drivers, Longitudinal Data, Patient Cohorts, Privacy, Ethics, Data Security, Patient Health Gene Therapy, Neurodegenerative Disorders, Parkinson's Disease, Precision Medicine, Genetics, Drug Development, Pharmaceuticals, Clinical Research, Regulatory Affairs, Patient-Centric Approach, Innovative Therapeutics, Disease-Modifying Therapies, Human Genetics
Website
characterbio.com prevailtherapeutics.com
Character Biosciences logo

About Character Biosciences

Character Biosciences is a precision medicine platform with the slogan "A patient-driven drug discovery platform for diseases of aging." The company, formerly known as Clover Therapeutics, is focused on unlocking the patterns of age-related diseases in diverse populations. Founded in 2018, their mis...

Prevail Therapeutics logo

About Prevail Therapeutics

Prevail Therapeutics, founded in 2017, is a pioneering biotech company focused on developing novel gene therapies aimed at addressing the root genetic causes of Parkinson’s disease and other neurodegenerative disorders. Their mission is to convert recent advances in human genetics and gene therapy t...

We will tell you when either one moves

BounceWatch watches Character Biosciences and Prevail Therapeutics for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Character Biosciences and Prevail Therapeutics — by email.

Frequently Asked Questions

Character Biosciences — A patient-driven drug discovery platform for diseases of aging. Prevail Therapeutics — Wholly owned subsidiary of Eli Lilly and Company. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Character Biosciences has raised $27.00M while Prevail Therapeutics has raised $1.29B.
Character Biosciences and Prevail Therapeutics operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Character Biosciences with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Character Biosciences on 12 Sep 2024, and Prevail Therapeutics on 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes